Maintz Laura, Benfadal Said, Allam Jean-Pierre, Hagemann Tobias, Fimmers Rolf, Novak Natalija
Department of Dermatology, University of Bonn, Germany.
J Allergy Clin Immunol. 2006 May;117(5):1106-12. doi: 10.1016/j.jaci.2005.11.041. Epub 2006 Feb 8.
A diminished histamine degradation based on a reduced diaminoxidase activity is suspected as a reason for non-IgE-mediated food intolerance caused by histamine. Atopic eczema (AE) is often complicated by relapses triggered by IgE-mediated allergy to different kinds of food. However, in a subgroup of patients with AE, allergy testing proves negative, although these patients report a coherence of food intake and worsening of AE and describe symptoms that are very similar to histamine intolerance (HIT).
It was the aim of our study to evaluate symptoms of HIT in combination with diaminoxidase levels in a total of 360 individuals consisting of patients with AE (n = 162) in comparison with patients with HIT (n = 124) without AE and healthy control volunteers (n = 85).
Histamine plasma level was determined with an ELISA and diaminoxidase serum activity with the help of radio extraction assays using [3H]-labeled putrescine-dihydrochloride as a substrate. Detailed clinical evaluations of characteristic features of AE and HIT were performed.
Reduced diaminoxidase serum levels leading to occurrence of HIT symptoms like chronic headache, dysmenorrhea, flushing, gastrointestinal symptoms, and intolerance of histamine-rich food and alcohol were significantly more common in patients with AE than in controls. Reduction of both symptoms of HIT and Severity Scoring of Atopic Dermatitis could be achieved by a histamine-free diet in the subgroup of patients with AE and low diaminoxidase serum levels.
Higher histamine plasma levels combined with a reduced histamine degradation capacity might influence the clinical course of a subgroup of patients with AE.
As HIT emerges in a subgroup of patients with AE, a detailed anamnestic evaluation of food intolerance and HIT symptoms complemented by an allergological screening for food allergy, a diet diary, and, in confirmed suspicion of HIT, measurement of diaminoxidase activity and a histamine-free diet should be undertaken.
基于二胺氧化酶活性降低的组胺降解减少被怀疑是组胺引起的非IgE介导的食物不耐受的原因。特应性皮炎(AE)常因对不同种类食物的IgE介导的过敏引发复发。然而,在一部分AE患者中,过敏测试结果为阴性,尽管这些患者报告食物摄入与AE病情恶化之间存在关联,并描述了与组胺不耐受(HIT)非常相似的症状。
我们研究的目的是评估360名个体中HIT的症状,并结合二胺氧化酶水平,这些个体包括AE患者(n = 162),与无AE的HIT患者(n = 124)以及健康对照志愿者(n = 85)进行比较。
采用酶联免疫吸附测定法(ELISA)测定血浆组胺水平,并借助以[3H] - 标记的盐酸腐胺为底物的放射性提取测定法测定二胺氧化酶血清活性。对AE和HIT的特征进行了详细的临床评估。
导致出现HIT症状(如慢性头痛、痛经、脸红、胃肠道症状以及对富含组胺的食物和酒精不耐受)的二胺氧化酶血清水平降低在AE患者中比在对照组中更为常见。在AE且二胺氧化酶血清水平低的患者亚组中,无组胺饮食可同时减轻HIT症状和特应性皮炎严重程度评分。
较高的血浆组胺水平与降低的组胺降解能力可能会影响一部分AE患者的临床病程。
由于HIT出现在一部分AE患者中,应进行详细的食物不耐受和HIT症状问诊评估,并辅以食物过敏的变态反应学筛查、饮食日记,在确诊怀疑HIT时,应测定二胺氧化酶活性并采用无组胺饮食。